From “MarketWatch”:

Processa Pharmaceuticals, Inc. Announces Presentation at Biotech Showcase 2024
George Ng, Processa’s CEO, will present a corporate overview at the Biotech Showcase 2024. The event is being held at the Hilton San Francisco Union Square on January 8 – 10, 2024 at 4:00pm PST. Management will be available for one-on-one meetings beginning on January 8, 2024. A replay of the presentation can be found on the Processa website or the webcast link. The company’s Next Generation Chemotherapy (NGC) drugs are currently under development and expected to benefit over 200,000 patients for each drug.

Contact:
Investors: Bret Shapiro, CORE IR, [email protected]
Company: Patrick Lin, (925) 683-3218, [email protected]



Read more: Processa Pharmaceuticals to Present at the Biotech Showcase